SCHEMBL19281815

SCHEMBL19281815

O=S1(=O)CCN(c2cccc(N3CCN(c4ccccc4)CC3)c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FAAH O00519 11/20 0.65
KDM4E B2RXH2 1/20 0.54
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
USP2 O75604 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 2/20 0.45
ALOX12 P18054 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2456271 0.90 KDM4E (0.63) FAAHKDM4ELMNAMAPTUSP2
Piperidine SCHEMBL17460237 0.88 FAAH (0.54) FAAHKDM4EUSP2TSHRMAPK1
SCHEMBL17460329 0.81 ADRA2C (0.62) FAAHKDM4ELMNAMAPTMEN1
SCHEMBL17460224 0.80 FAAH (1.00) FAAH
SCHEMBL14322235 0.80 FAAH (0.49) FAAHKDM4EMEN1KMT2AALDH1A1
SCHEMBL10053476 0.80 ADRB1 (0.59) FAAHKDM4EMAPTALDH1A1
SCHEMBL17460235 0.80 FAAH (0.52) FAAHKDM4EMEN1KMT2AALDH1A1
SCHEMBL14696890 0.80 ALDH1A1 (0.71) FAAHKDM4ELMNAMAPTUSP2
SCHEMBL12551055 0.79 KDM4E (0.61) FAAHKDM4EUSP2TSHRMAPK1
SCHEMBL17460198 0.79 MAPT (0.76) FAAHKDM4ELMNAMAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11214578-B2 Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof NORTHEASTERN UNIVERSITY (US) 2022-01-04 US disclosed
US-20200148696-A1 Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof NORTHEASTERN UNIVERSITY 2020-05-14 US disclosed
US-10570146-B2 Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof NORTHEASTERN UNIVERSITY (US) 2020-02-25 US disclosed
US-20170247387-A1 UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF NORTHEASTERN UNIVERSITY 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11214578-B2 Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof FAAH, FAAH2, MGLL FAAH 1/4885KDM4E 1349/4885LMNA 2835/4885
US-10570146-B2 Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof FAAH, FAAH2, MGLL FAAH 1/4885KDM4E 1493/4885LMNA 4274/4885
US-20170247387-A1 UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF FAAH, FAAH2, MGLL FAAH 1/4885KDM4E 1301/4885LMNA 3441/4885
US-20200148696-A1 Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof FAAH, MGLL, FAAH2 FAAH 1/4885KDM4E 1810/4885LMNA 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.